CTOs on the Move

Aspen Pharmacare Canada

www.aspenpharma.ca

 
We have a proud heritage dating back more than 160 years and is committed to sustaining life and promoting healthcare through increasing access to our high quality, affordable medicines and products. As a leading global player in specialty, branded and generic pharmaceuticals, we have an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. We continue to increase the number of lives benefiting from our products that reach more than 150 countries. In line with the our commercial, production and territorial strategies, we have identified Thrombosis, Anaesthetics, High ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $1-10 Million
  • www.aspenpharma.ca
  • 8 – 1155 North Service Road West
    Oakville, ON CAN L6M 3E3
  • Phone: 844.330.1213

Executives

Name Title Contact Details

Similar Companies

TB Alliance

TB Alliance is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Taylst

Taylst is a Kirkland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kalypsys

Kalypsys, Inc. is a Del Mar, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Precision Life Sciences

RESULTS ARE IN OUR DNA Fostering partnerships within the Life Science industry to enable innovation and positive outcomes. CLIENTS JOB SEEKERS Company We Are Precision Life Sciences Precision Life Sciences, a WBE (Woman-Owned Business Enterprise), was ...

Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company`s lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. The company also has a portfolio of programs, including PIPE-307, focused on remyelination and axonal repair, to address a range of neurological disorders, including multiple sclerosis.